4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one
C22H13ClF3N5O — CID 175617260
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one
4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one (PubChem CID 175617260) has the molecular formula C22H13ClF3N5O and a molecular weight of 455.83 g/mol. Its IUPAC name is 4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one.
Molecular Properties
| Compound Name | 4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one |
|---|---|
| PubChem CID | 175617260 |
| Molecular Formula | C22H13ClF3N5O |
| Molecular Weight | 455.83 g/mol |
| Exact Mass | 455.08 |
| IUPAC Name | 4-amino-1-(4-chlorophenyl)-3-pyrazolo[1,5-a]pyridin-6-yl-7-(trifluoromethyl)-1,8-naphthyridin-2-one |
| SMILES | Nc1c(-c2ccc3ccnn3c2)c(=O)n(-c2ccc(Cl)cc2)c2nc(C(F)(F)F)ccc12 |
| InChI | InChI=1S/C22H13ClF3N5O/c23-13-2-5-15(6-3-13)31-20-16(7-8-17(29-20)22(24,25)26)19(27)18(21(31)32)12-1-4-14-9-10-28-30(14)11-12/h1-11H,27H2 |
| InChIKey | DKXQMGFHNIBYSI-UHFFFAOYSA-N |
| XLogP | 4.95 |
| TPSA | 78.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.83 |
| LogP ≤ 5 | 4.95 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175617260 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.